본문 바로가기

Quantitative Prediction of Posttransplant Hepatocellular Carcinoma Prognosis Using ADV Score: Validation with Korea-Nationwide Transplantation Registry Database

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
JOURNAL OF GASTROINTESTINAL SURGERY27(7) · pp.1353 · 2023
피인용
Web of Science 9Scopus 10
FWCI (Scopus)
1.25
JCR IF
JCR 2022 3.2
ISSN
1091-255X

저자

  1. Park, Gil-Chun제1저자Univ Ulsan, Asan Med Ctr, Dept Surg, Coll Med, Olymp ro 43-gil 88, Seoul 05505, South Korea
  2. Hwang, Shin교신저자Univ Ulsan, Asan Med Ctr, Dept Surg, Coll Med, Olymp ro 43-gil 88, Seoul 05505, South Korea
  3. You, Young Kyoung교신저자Catholic Univ Korea, Coll Med, Dept Surg, Seoul 06591, South Korea
  4. Choi, YoungRokSeoul Natl Univ, Dept Surg, Coll Med, Seoul, South Korea
  5. Kim, Jong ManSungkyunkwan Univ, Samsung Med Ctr, Dept Surg, Sch Med, Seoul, South Korea
  6. Joo, Dong JinYonsei Univ, Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea
  7. 류제호Pusan Natl Univ, Pusan Natl Univ Yangsan Hosp, Dept Surg, Sch Med, Pusan, South Korea
  8. Choi, DonglakCatholic Univ Daegu, Dept Surg, Daegu, South Korea
  9. Kim, Bong-WanAjou Univ, Dept Liver Transplantat & Hepatobiliary Surg, Sch Med, Suwon, South Korea
  10. Kim, Dong-SikKorea Univ, Dept Surg, Div HBP Surg & Liver Transplantat, Coll Med, Seoul, South Korea
  11. Nah, Yang WonUniv Ulsan, Ulsan Univ Hosp, Dept Surg, Coll Med, Ulsan, South Korea
  12. Kang, Koo JeongKeimyung Univ, Dongsan Med Ctr, Dept Surg, Sch Med, Daegu, South Korea
  13. Cho, Jai YoungSeoul Natl Univ, Seoul Natl Univ Bundang Hosp, Dept Surg, Coll Med, Seongnam, South Korea
  14. Yu, Hee ChulJeonbuk Natl Univ, Dept Surg, Med Sch, Jeonju, South Korea
  15. Kim, Deok GieYonsei Univ, Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea

초록

Objective: The aim of this study is to validate the prognostic impact of ADV score (α-fetoprotein [AFP]–des-γ-carboxyprothrombin [DCP]–tumor volume [TV] score) for predicting prognosis of hepatocellular carcinoma (HCC) following liver transplantation (LT). Background: ADV score has been reported as a prognostic surrogate biomarker of HCC following LT and hepatectomy. Methods: The study patients were 1599 LT recipients selected from the Korean Organ Transplantation Registry database. Results: Deceased-donor and living-donor LTs were performed in 143 and 1456 cases, respectively. Weak correlation was present among AFP, DCP, and TV. The viable HCC group showed ADV score-dependent disease-free survival (DFS) and overall patient survival (OS) rates from 1log to 10log (p<0.001). Prognosis of complete pathological response group was comparable to that of ADV score <1log (p≥0.099). ADV score cutoff of 5log (ADV-5log) for DFS and OS was obtained through receiver operating characteristic curve analysis with area under the curve ≥0.705. Both ADV-5log and Milan criteria were independent risk factors for DFS and OS, and their prognostic impacts were comparable to each other. Combination of these two factors resulted in further prognostic stratification, showing hazard ratios for DFS and OS as 2.98 and 2.26 respectively for one risk factor and 7.92 and 8.19 respectively for two risk factors (p<0.001). ABO-incompatible recipients with ADV score ≥8log or two risk factors showed higher recurrence rates. Conclusions: This validation study revealed that ADV score is a reliable surrogate biomarker for posttransplant HCC prognosis, which can be used for selecting LT candidates and guiding risk-based posttransplant follow-up surveillance.

키워드

Hepatocellular carcinomaPredictionPrognosisTumor biologyTumor markerDONOR LIVER-TRANSPLANTATIONSELECTION CRITERIACHEMOEMBOLIZATIONRECURRENCEMRECISTVOLUMEDEATH

식별자

Scopus EID
2-s2.0-85152389319
WoS UID
000967207700001